Literature DB >> 16704936

Size-exclusion chromatography of heparin oligosaccharides at high and low pressure.

André Ziegler1, Joseph Zaia.   

Abstract

Recent findings on specific and non-specific interactions of glycosaminoglycans (GAGs) accentuate their pivotal role in biology and the call for improved sequencing tools. The present study evaluates size-exclusion chromatography (SEC) of heparin oligosaccharides at high and low pressure, requiring amounts as low as 0.2 microgram, using conventional UV detection after depolymerization with heparin lyases. Because of their high charge at physiological pH, SEC elution volumes of heparin oligosaccharides depend on both molecular size and charge repulsion from the matrix. As a consequence, SEC elution volumes of GAGs are smaller than those of globular proteins of similar molecular weight, and this might be exploited. Accordingly, larger heparin oligosaccharides are best separated according to their size at high ionic strength of the mobile phase (>30 mM); in contrast, disaccharides are best separated according to their charge at low ionic strength, compatible with on-line coupling to mass spectrometry. Optimized SEC affords separation of characteristic heparin trisaccharides that contain uronic acid at the reducing end and suggest cellular storage of heparin as a free glycan.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16704936     DOI: 10.1016/j.jchromb.2006.04.013

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  14 in total

1.  Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry.

Authors:  Hicham Naimy; Nancy Leymarie; Joseph Zaia
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

2.  High-resolution preparative separation of glycosaminoglycan oligosaccharides by polyacrylamide gel electrophoresis.

Authors:  Tatiana N Laremore; Mellisa Ly; Kemal Solakyildirim; Dmitri V Zagorevski; Robert J Linhardt
Journal:  Anal Biochem       Date:  2010-03-06       Impact factor: 3.365

3.  Quality control considerations for size exclusion chromatography with online ICP-MS: a powerful tool for evaluating the size dependence of metal-organic matter complexation.

Authors:  Erica R McKenzie; Thomas M Young
Journal:  Water Sci Technol       Date:  2013       Impact factor: 1.915

4.  Analysis of Glycosaminoglycans Using Mass Spectrometry.

Authors:  Gregory O Staples; Joseph Zaia
Journal:  Curr Proteomics       Date:  2011       Impact factor: 0.837

5.  Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions.

Authors:  Hicham Naimy; Jo Ann Buczek-Thomas; Matthew A Nugent; Nancy Leymarie; Joseph Zaia
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

6.  A comprehensive compositional analysis of heparin/heparan sulfate-derived disaccharides from human serum.

Authors:  Wei Wei; Milady R Niñonuevo; Anish Sharma; Lieza M Danan-Leon; Julie A Leary
Journal:  Anal Chem       Date:  2011-04-19       Impact factor: 6.986

Review 7.  On-line separations combined with MS for analysis of glycosaminoglycans.

Authors:  Joseph Zaia
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

8.  A chip-based amide-HILIC LC/MS platform for glycosaminoglycan glycomics profiling.

Authors:  Gregory O Staples; Michael J Bowman; Catherine E Costello; Alicia M Hitchcock; James M Lau; Nancy Leymarie; Christine Miller; Hicham Naimy; Xiaofeng Shi; Joseph Zaia
Journal:  Proteomics       Date:  2009-02       Impact factor: 3.984

9.  Organ-specific heparan sulfate structural phenotypes.

Authors:  Xiaofeng Shi; Joseph Zaia
Journal:  J Biol Chem       Date:  2009-02-25       Impact factor: 5.157

10.  Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry.

Authors:  Hicham Naimy; Nancy Leymarie; Michael J Bowman; Joseph Zaia
Journal:  Biochemistry       Date:  2008-02-09       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.